ViroGates A/S (CPH:VIRO)

Denmark flag Denmark · Delayed Price · Currency is DKK
12.30
-0.15 (-1.20%)
At close: Feb 26, 2026
28.80%
Market Cap 114.17M
Revenue (ttm) 8.11M
Net Income (ttm) -12.39M
Shares Out 9.28M
EPS (ttm) -1.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 954
Open 12.30
Previous Close 12.45
Day's Range 12.30 - 12.30
52-Week Range 5.98 - 17.40
Beta 0.71
RSI 49.31
Earnings Date Mar 26, 2026

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer. The company’s product includes suPARnostic TurbiLatex, a latex particle-enhan... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 7
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol VIRO
Full Company Profile

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.

Financial Statements

News

There is no news available yet.